BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16341140)

  • 1. Papillomaviruses as targets for cancer gene therapy.
    Shillitoe EJ
    Cancer Gene Ther; 2006 May; 13(5):445-50. PubMed ID: 16341140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses.
    Alvarez-Salas LM; Benítez-Hess ML; DiPaolo JA
    Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer.
    Hamada K; Shirakawa T; Gotoh A; Roth JA; Follen M
    Gynecol Oncol; 2006 Dec; 103(3):820-30. PubMed ID: 16908054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human papillomaviruses, cell cycle and cervical cancer].
    Mougin C; Humbey O; Gay C; Riethmuller D
    J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):13-20. PubMed ID: 10675829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.
    Yugawa T; Kiyono T
    Rev Med Virol; 2009 Mar; 19(2):97-113. PubMed ID: 19156753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillomaviruses as targets for cancer gene therapy.
    Shillitoe EJ; Kamath P; Chen Z
    Cancer Gene Ther; 1994 Sep; 1(3):193-204. PubMed ID: 7621251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of human papillomavirus type 18-specific antisense oligonucleotides on the transformed phenotype of human carcinoma cell lines.
    Steele C; Cowsert LM; Shillitoe EJ
    Cancer Res; 1993 May; 53(10 Suppl):2330-7. PubMed ID: 7683572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer.
    Fujii T; Saito M; Iwasaki E; Ochiya T; Takei Y; Hayashi S; Ono A; Hirao N; Nakamura M; Kubushiro K; Tsukazaki K; Aoki D
    Int J Oncol; 2006 Sep; 29(3):541-8. PubMed ID: 16865269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillomaviruses and cancer: from basic studies to clinical application.
    zur Hausen H
    Nat Rev Cancer; 2002 May; 2(5):342-50. PubMed ID: 12044010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic diversity of human papillomavirus type 16 E6, E7, and L1 genes in Italian women with different grades of cervical lesions.
    Cento V; Ciccozzi M; Ronga L; Perno CF; Ciotti M
    J Med Virol; 2009 Sep; 81(9):1627-34. PubMed ID: 19626616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of human papillomavirus types in cervical and oral cancers in central India.
    Gheit T; Vaccarella S; Schmitt M; Pawlita M; Franceschi S; Sankaranarayanan R; Sylla BS; Tommasino M; Gangane N
    Vaccine; 2009 Jan; 27(5):636-9. PubMed ID: 19056450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus: its identity and controversial role in oral oncogenesis, premalignant and malignant lesions (review).
    Campisi G; Panzarella V; Giuliani M; Lajolo C; Di Fede O; Falaschini S; Di Liberto C; Scully C; Lo Muzio L
    Int J Oncol; 2007 Apr; 30(4):813-23. PubMed ID: 17332919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Papillomaviruses and human tumors].
    Vonka V; Hamsíková E; Sobotková E; Smahel M; Kitasato H; Sainerová H; Ludvíková V; Zák R; Kanka J; Kolár Z; Kovarík J
    Cas Lek Cesk; 2000 Dec; 139 Suppl 1():27-9. PubMed ID: 11262898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomaviruses and cervical cancer.
    DiMaio D; Liao JB
    Adv Virus Res; 2006; 66():125-59. PubMed ID: 16877060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis.
    Divya CS; Pillai MR
    Mol Carcinog; 2006 May; 45(5):320-32. PubMed ID: 16526022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV and cervical cancer: updates on an established relationship.
    Subramanya D; Grivas PD
    Postgrad Med; 2008 Nov; 120(4):7-13. PubMed ID: 19020360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma.
    Lie AK; Kristensen G
    Expert Rev Mol Diagn; 2008 Jul; 8(4):405-15. PubMed ID: 18598223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus infection, cancer & therapy.
    Grm HS; Bergant M; Banks L
    Indian J Med Res; 2009 Sep; 130(3):277-85. PubMed ID: 19901437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
    Vinokurova S; Wentzensen N; Kraus I; Klaes R; Driesch C; Melsheimer P; Kisseljov F; Dürst M; Schneider A; von Knebel Doeberitz M
    Cancer Res; 2008 Jan; 68(1):307-13. PubMed ID: 18172324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.